DermWire | Newest Articles Newest Articles en-us Tue, 19 Jun 2018 23:43:12 GMT Tue, 19 Jun 2018 23:43:12 GMT DermWire New Patient-Centered Panel Helps BioPharmX Define its Role in the Future of Dermatology BioPharmX Corporation has formed a Special Advisory Council of thought leaders from various disciplines to help the company embrace patient centricity in its products, pricing, and market access considerations. The advisors, who bring decades of experience in fields beyond dermatology -- ranging from regulatory pathways to market access and from infectious diseases to antibiotic resistance -- will inform the company's efforts by providing the kind of strategic expertise needed to position… Tue, 19 Jun 2018 04:00:00 GMT Michael Mazen Jafar is New Chief Marketing Officer at Evolus Evolus, Inc. has expanded its management team with the appointment of Michael Mazen Jafar as Chief Marketing Officer. Mr. Jafar joins Evolus from Allergan where he most recently served as Vice President, Medical Aesthetics. At Allergan Mr. Jafar led the commercial launch of Juvederm Voluma®, which has been recognized as not only one of the largest launches in the medical aesthetics category, but also the most successful, as measured by year one sales. He also led product development and m… Mon, 18 Jun 2018 04:00:00 GMT Valeant: FDA Issues Complete Response Letter for Duobrii Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. has received a Complete Response Letter (CRL) from the US FDA regarding the company's New Drug Application (NDA) for DUOBRII™ (halobetasol propionate and tazarotene) (IDP-118) lotion in the treatment of plaque psoriasis. Mon, 18 Jun 2018 04:00:00 GMT New Data from DermTech Presented at International Investigational Dermatology Meeting DermTech, Inc., has announced the publication of two clinical study abstracts at the 2018 International Investigational Dermatology meeting in Orlando, Fl. A real world clinical utility study, “Real-world experience and clinical utility of a non-invasive gene expression test for primary cutaneous melanoma and validation against high risk driver mutations in BRAF, NRAS and the TERT promoter," demonstrated that combining gene expression and mutation analyses enhances the ability to non-… Fri, 15 Jun 2018 04:00:00 GMT Derm Brands Dove, Neutrogena, L'Oreal Among Top Skincare Social Influencers Engagement Labs’ TotalSocial® ranking of the top personal care and beauty brands in the US based on social influence show several popular dermatology brands in the Top 10, including Dove, Neutrogena, and L’Oreal. Engagement Labs is a data and analytics firm that focuses on the entire social ecosystem and its impact on business The analysis is unique in that it combines offline and online consumer conversations. It is based on Engagement Labs' proprietary TotalSocial da… Fri, 15 Jun 2018 04:00:00 GMT eRelevance Launches Suite of Services to Support Lead Conversion eRelevance Corporation has launched a suite of tech-powered services to help SMBs grow more cost-effectively. The services drive more demand, lower advertising costs, and improve lead conversion. "We are uniquely focused on changing small businesses forever by bringing big-company consumer engagement capability to them as affordable, turnkey services," says eRelevance Co-founder and CEO Bob Fabbio. "We have consistently heard from SMBs that they face challenges trying to grow… Thu, 14 Jun 2018 04:00:00 GMT Xact Nabs Best of Hot Topics at ASAPS 2018 Cypris Medical, Inc.’s Xact technology took home the “Best of Hot Topics” award at the American Society for Aesthetic Plastic Surgery (ASAPS) meeting in New York. Xact technology is a minimally invasive face and neck lifting suturing device cleared by the US Food and Drug Administration in 2017. “Our core technology, Xact, replaces two of the oldest technologies in surgery, the 100 year-old needle holder and the 70 year-old forceps,” says Cypris CEO Dan Holton… Wed, 13 Jun 2018 04:00:00 GMT Older Melanoma Patients May Have Better Response to Immune Checkpoint Blockade Therapy Patient age correlates with response to immunotherapy in melanoma, and depleting regulatory T cells in young patients may have a therapeutic potential to enhance response in younger patients, according to research from The Wistar Institute. Study results were published online in Clinical Cancer Research. Not all patients benefit from immune checkpoint blockade therapy and some responders eventually develop resistance, highlighting the need for biomarkers that could help predict patient ben… Wed, 13 Jun 2018 04:00:00 GMT Restoration Robotics Launches Continuing Education Master Class for ARTAS System Restoration Robotics, Inc. is launching a continuing education Master Class Series for its ARTAS® Robotic Hair Restoration System to train physicians on best practices and the most up-to-date techniques for the technology. The Master Class Series will enable users to provide exceptional results to male aesthetic patients. The ARTAS Hair Transplant System is the first and only robotic system in the world designed to aid surgeons in hair restoration procedures. The first Master Class was le… Tue, 12 Jun 2018 04:00:00 GMT ThermiVa: First-ever Data Show Vaginal Regeneration Thermi’s ThermiVa® device has been shown to deliver significant improvements in common vaginal disorders and improve sexual satisfaction, according to a study published in Dermatologic Surgery. Since it was cleared by the FDA in 2013, ThermiVa has been used in more than 85,000 procedures worldwide. It is part of the ThermiRF system. The study demonstrated that treatment with ThermiVa resulted in significant improvements in atrophic vaginitis, vulvovaginal laxity and sexual satisfact… Mon, 11 Jun 2018 04:00:00 GMT PellePharm Presents New Data in BCC PellePharm, a late clinical-stage biopharmaceutical company committed to targeting rare dermatologic conditions at their source, presented new data from its clinical and scientific research programs at the International Investigative Dermatology (IID) Meeting in Orlando, FL. The data, presented in three posters, highlighted PellePharm's lead clinical program, patidegib topical gel, in patients with basal cell carcinomas (BCCs) and epidemiological data on sporadic, high frequency BCCs. The… Fri, 8 Jun 2018 04:00:00 GMT Galderma Global Survey Assesses Burden of Rosacea Recently released findings from Galderma’s global survey on the true burden of rosacea suggest a need for dermatologists and doctors to proactively open a dialogue with patients about the true burden of rosacea. An expert-authored report entitled Rosacea: Beyond the visible, available on the British Medical Journal (BMJ) website, reveals the true extent of the psychosocial burden of the disease. Every second patient reported that they would potentially be willing to trade six … Fri, 8 Jun 2018 04:00:00 GMT InMode: New EmbraceRF Solution Introduces Subdermal Adipose Remodeling Introducing the concept of Subdermal Adipose Remodeling, InMode Aesthetic Solutions is launching EmbraceRF to target the neck and face through a powerful combination of InMode’s proprietary technologies: FaceTite and Morpheus8. InMode says the new facial contouring solution address a treatment gap in current modalities offered to patients by introducing the concept of subdermal adipose remodeling of the face. The EmbraceRF FaceTite procedure generates heat to “mold” the fat … Fri, 8 Jun 2018 04:00:00 GMT Opdivo Data: Superior Recurrence-Free Survival Versus Ipilimumab Updated results from the Phase 3 CheckMate -238 trial evaluating Opdivo (nivolumab, Bristol-Myers Squibb Company) versus Yervoy (ipilimumab, Bristol-Myers Squibb Company) in patients with stage IIIB/C or stage IV melanoma who are at high risk of recurrence following complete surgical resection show that Opdivo continued to demonstrate statistically longer recurrence-free survival (RFS) of 62.6%. Recurrence-free survival was 50.2% for Yervoy (HR: 0.66, P<0.0001) at a minimum follow-up of 24 mo… Fri, 8 Jun 2018 04:00:00 GMT White Coats, Scrubs Top Patient Preferences for Doctor’s Attire What doctors wear matters…a lot, according to the largest-ever study of patient preferences for doctors’ attire. Just more than half of the 4,062 patients surveyed in the clinics and hospitals of ten major medical centers said that what physicians wear is important to them -- and more than one-third said that what a doctor wears influences their satisfaction with their care. The findings appear in BMJ Open. “In medicine, the dress code is quite heterogeneous, but as… Wed, 6 Jun 2018 04:00:00 GMT Luma Therapeutics Launches Novel illuvinate Phototherapy System Luma Therapeutics has launched illuvinate as an innovative and modern twist on the Goeckerman regimen. By combining a narrowband UVB LED light with patented hydrogels containing coal tar micro-globules, illuvinate increases the skin's hydration, decreases inflammation, and suppresses overactive immune cells. Clinical trial data show that the system enables those suffering from chronic skin conditions, such as psoriasis, eczema or vitiligo, to experience clear skin after performing therapy… Wed, 6 Jun 2018 04:00:00 GMT PD1 Blocker Shrinks Advanced Squamous Cell Skin Cancers A checkpoint inhibitor shrinks the tumors of nearly half of patients with an incurable, advanced form of squamous cell carcinoma, an international team reports in the New England Journal of Medicine. “These results mark a potential paradigm shift in the treatment of patients with advanced cutaneous squamous cell carcinoma, who to date have had very limited results with chemotherapy and targeted therapies,” says lead author Michael Migden, M.D., associate professor of Dermatology a… Mon, 4 Jun 2018 04:00:00 GMT Spironolactone May Be an Alternative to Antibiotics in Female Acne The diuretic drug spironolactone may be just as effective as antibiotics for the treatment of women’s acne, report researchers from the Perelman School of Medicine at the University of Pennsylvania. The study, published in the Journal of Drugs and Dermatology, found patients who were originally prescribed spironolactone changed to a different drug within one year at almost the same rate as those who were prescribed antibiotics. The prescription change is a proxy for ineffectiveness, sin… Mon, 4 Jun 2018 04:00:00 GMT Avon Receives Patents for Rotational Infinite Effects Skincare Technology Avon has been issued two new patents for new technology currently included in the ANEW Reversalist Infinite Effects and most recently the ANEW Ultimate Infinite Effects products. The rotational regimen is designed to make retinol, a gold standard ingredient for skin care, work even harder. Avon introduced ANEW Reversalist Infinite Effects in 2017 as the world's first rotational anti-aging night cream that provides continuous results that do not stall over a full year. Long-term benefit wa… Mon, 4 Jun 2018 04:00:00 GMT Eclipse Announces New Board Members Meet Eclipse’s Medical and Scientific Advisory Board (M&SAB) for 2018. The 2018 Eclipse M&SAB includes: Dr. Sanjay Batra Dr. Batra obtained his PhD in physiology from the University of Ottawa, Canada and completed post-doctoral training in Japan and Switzerland. He is a Fellow of the American College of Cardiology. Prior to joining Eclipse as the President of Regenerative Medicine, Dr. Batra accepted an associate professor faculty position at the Institute for Regenerati… Mon, 4 Jun 2018 04:00:00 GMT Gryphon Investors Makes Majority Investment in Water's Edge Dermatology Gryphon Investors has made a majority investment in Water’s Edge Dermatology. Terms of the transaction were not disclosed. Gryphon Investors is a San Francisco-based middle market private equity firm. A leading provider of comprehensive dermatology services in over 30 locations in Florida, the Water’s Edge management team has retained a significant ownership position in the company. “Since founding Water’s Edge 20 years ago, we have built a dermatology practice tha… Mon, 4 Jun 2018 04:00:00 GMT One In Two Latina Influencers Favor Complementing Diet and Exercise with Non-Surgical Body Contouring More than 50 percent of Latina Influencers think that non-surgical body contouring works well with diet and exercise, according to an Allergan-sponsored survey. The survey results were part of a panel discussion with Vivian Bucay, MD a San Antonio, Texas dermatologist; Gia Fey, Curveygirls Fitness trainer and creator of Body by Gia; and Ana Flores, Founder and Chief Executive Officer of #WeAllGrow Latina Network, an organization dedicated to leveraging social influence to grow a community of … Thu, 31 May 2018 04:00:00 GMT Skin Cancer Survey Spotlights Frustration with Perceptions of "Less Serious" Condition People living with skin cancer struggle with perceptions that their condition is less serious than other types of cancer despite significant physical and emotional impact, according to Skin Cancer In America 2018, a national survey by Health Union, LLC of people diagnosed with the condition. One respondent expressed being “shocked and disheartened” by people who think skin cancer can simply be “zapped off at the dermatologist’s office” and, as a result, having &l… Thu, 31 May 2018 04:00:00 GMT New CFO at Evolus, Inc. Lauren Silvernail is the new Chief Financial Officer and Executive Vice President, Corporate Development at Evolus, Inc. Silvernail joins Evolus from Revance Therapeutics where she most recently served as Chief Financial Officer and Chief Business Officer. Prior to her time at Revance Therapeutics, Silvernail was Chief Financial Officer and Vice President, Corporate Development at ISTA Pharmaceuticals Inc. working to grow the business from development stage through commercialization and into … Wed, 30 May 2018 04:00:00 GMT DermTech: Carcinome Clinical Study Enrollment Complete DermTech, Inc., the global leader in non-invasive molecular dermatology, announced completion of enrollment in the Carcinome™ clinical study. The goal of the Carcinome™ study is to develop a non-invasive genomic test to differentiate basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) from non-cancerous lesions like actinic keratosis. More than 600 patients were enrolled in this study. Over 4 million cases of BCC and 1 million cases of SCC are diagnosed each year in the U… Tue, 29 May 2018 04:00:00 GMT